RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Sensible Biotechnologies

Sensible Biotechnologies

Sensible Biotechnologies is a biotechnology company that develops cell-based technologies for the design of mRNA therapeutics.

Latest funding

$47M Series A ·

Led by Oxford Science Enterprises · Source: firstwordpharma.com

Total raised: $51.2M across 2 sourced rounds

All 3 rounds ↓
Website: sensible.bio.
X: @sensible_bio · 366 followers.
LinkedIn: linkedin.com.
Sectors: Healthcare, Therapeutics, Synthetic Biology, Biotech, Manufacturing, Biotechnology.
Stage: Series A.
Based in: Oxford, United Kingdom.
Founded: 2021.
Total raised: $51.2M in 2 sourced rounds.
Last round: Oct 6, 2026 · 37 days ago.
On Recent Funding since: Sep 28, 2026.

Signals

X account@sensible_bio · created Aug 21, 2021 (5 years old) · 366 followers
Website registeredAug 9, 2021 (5 years old)
TIMELINE · MONEY RAISED

Sensible Biotechnologies | 605 days from website to first raise on record

@sensible_bio·Raised $51M in 2 sourced rounds·2 signals before the first raise
$13M$26M$38M$51MSEPJUNMARDECSEPJUNMARDEC$51M||WEBSITE CREATED · AUG 9, 2021||X ACCOUNT CREATED @SENSIBLE_BIO · AUG 21, 2021$4.2M Pre Seed · Apr 6, 2023$4.2M PRE-SEED · APR '23$47M Series A · Oct 6, 2026$47M A · OCT '26

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

  1. Series A · $47M
  2. Pre Seed · $4.2M
  3. X account created
  4. Website created
  5. Summer 2021
    YY Combinator · batch

Founders and team

Investors

Companies like Sensible Biotechnologies

Other companies backed by Oxford Science Enterprises

Oxford Science Enterprises portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/sensible-biotechnologies (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy